Has a woman cleared HIV all by herself?

Publicly released:
International

A patient diagnosed with HIV in 2013 may have cleared the virus all by herself, according to international researchers who say the extremely rare but possible case may provide hope for a future HIV cure. The 30-year-old woman, referred to as “The Esperanza Patient”, was first diagnosed with HIV in March 2013. But throughout eight years of follow-up, researchers tried 10 different HIV tests and looked at billions of cells, and could not find detectable virus levels. There have only been two other cases of this in patients who have undergone treatment, and the researchers say the Esperanza Patient seems to resemble the famous Berlin Patient who successfully received stem cell transplantation. Researchers say they cannot exactly prove she has been cured, but continue to monitor the Esperanza Patient with hopes this will assist in future developments in HIV treatments.

Media release

From: American College of Physicians

‘Esperanza Patient’ possible case of natural cure of HIV infection without stem cell transplant
Case raises hopes that a sterilizing cure could be induced in larger numbers of people living with HIV

A patient diagnosed with HIV-1 infection in 2013 may have achieved a natural sterilization cure without stem cell transplantation. Genome-intact and replication-competent HIV-1 were not detected over 8 years of follow up despite analysis of massive numbers of cells from blood and tissue. These observations raise the possibility that a sterilizing cure may be an extremely rare but possible outcome in HIV-infection. The findings are published in Annals of Internal Medicine.

Antiretroviral therapy (ART) can effectively suppress viral replication in HIV-1 but a sterilizing cure during natural disease is currently considered elusive. A sterilizing cure refers to the complete elimination of replication-competent proviruses and has only ever been achieved by 2 patients, both of whom had leukemia and underwent allogenic hematopoietic stem cell transplants. A small subgroup of patients living with HIV, frequently called “elite controllers” have undetectable virus via polymerase chain reaction (PCR) assay, but reservoirs of replication-competent HIV-1 persist.

Researchers from Ragon Institute of MGH, MIT and Harvard and INBIRS Institute (UBA-CONICET) conducted a detailed investigation of an elite controller with undetectable virus after more than 7 years without ART. The investigators looked for viral particles in more than 1.5 billion cells from blood and tissue samples taken over a more than 4-year period. At no point was replication-competent virus detected, suggesting a naturally occurring sterilization cure. According to the researchers, these findings raise hopes that a sterilizing cure can be induced in larger numbers of people living with HIV. This patient is being referred to as the Esperanza Patient.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research American College of Physicians, Web page The URL will go live after the embargo ends.
Editorial / Opinion American College of Physicians, Web page The URL will go live after the embargo ends.
Journal/
conference:
Annals of Internal Medicine
Research:Paper
Organisation/s: Universidad de Buenos Aires, Argentina
Funder: Dr. Yu is supported by National Institutes of Health (NIH) grants HL134539, AI116228, AI078799, DA047034, AI155171, and AI150396 and by the Bill & Melinda Gates Foundation (INV-002703). Dr. Lichterfeld is supported by NIH grants AI135940, AI114235, AI117841, AI120008, AI152979, AI130005, DK120387, and AI155233 and by amfAR (110181-69- RGCV). Drs. Lichterfeld and Yu are Associated Members of the BEAT-HIV Martin Delaney Collaboratory (UM1 AI126620). This project was funded in whole or in part by federal funds from the Frederick National Laboratory for Cancer Research under contract no. HHSN261200800001E. This research was supported in part by the Intramural Research Program of the NIH, Frederick National Laboratory, Center for Cancer Research.
Media Contact/s
Contact details are only visible to registered journalists.